Description  Claims  Drawing  Cited references 

US61312982A   [0001] 
WO2004059285A   [0007] 
US20070154458A   [0059] 
US61312982B   [0087] 

J. Immunol.   [0004] 
Cancer Research   [0005] 
J. Surgical Research   [0006] 
Rernington: The Science and Practice of Pharmacy   [0029] 
Clin Cancer Res   [0030] 
Nat Rev Cancer   [0031] 
Cancer Gene Ther   [0031] 
Lancet Oncol   [0031] 
Curr Gene Ther   [0031] 
Cancer Gene Ther   [0031] 
Blood   [0031] 
Lancet Oncol   [0031] 
J Clin Invest   [0031] 
Adv Exp Med Biol   [0031] 
J Transl Med   [0031] 
Natural killer cell-mediated eradication of neuroblastoma metastases to bone marrow by targeted interleukin-2 therapy   [0050] 
Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch variants of monoclonal antiganglioside GD2 antibody 14.18   [0050] 
Linear PADRE T helper epitope and carbohydrate B cell epitope conjugates induce specific high titer IgG antibody responses   [0051] 
Modification of delivery system enhances MHC nonrestricted immunogenicity of V3 loop region of HIV-1 gp120   [0051] 
DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses   [0051] 
Surfactant protein A modulates the differentiation of murine bone marrow-derived dendritic cells   [0052] 
Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function   [0054] 
Induction of protective immune responses against NXS2 neuroblastoma challenge in mice by immunotherapy with GD2 mimotope vaccine and IL-15 and IL-21 gene delivery   [0054]  [0055]  [0066] 
Oncolytic virotherapy as a personalized cancer vaccine   [0074] 
Disrupting tumour blood vessels   [0079] 
Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes   [0081]